Cowen Starts 22nd Century Group (XXII) at Outperform

July 23, 2021 5:49 AM EDT
Get Alerts XXII Hot Sheet
Price: $3.04 -1.94%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 24
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Cowen analyst Vivien Azer initiates coverage on 22nd Century Group (NYSE: XXII) with a Outperform rating and a price target of $5.00.

The analyst comments "We initiate coverage of XXII with an Outperform rating. As a leader in plant genetics, XXII is positioned to capitalized on major near-term commercialization catalysts including potential FDA MRTP designation for its VLN cigarettes and the monetization of its biosynthesis IP starting in 2H21 as well as longer term tobacco regulatory tailwinds. Our $5 PT assumes a 10x FY2 revenue multiple."

For an analyst ratings summary and ratings history on 22nd Century Group click here. For more ratings news on 22nd Century Group click here.

Shares of 22nd Century Group closed at $3.18 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities

Cowen & Co, FDA